Working with NKT cells - Pitfalls and practicalities

Current Opinion in Immunology

Volumn 17, Issue 4 SPEC. ISS., 2005, Pages 448-454

  Berzins, Stuart P ^a   Smyth, Mark J ^b   Godfrey, Dale I ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b PETER MACCALLUM CANCER CENTRE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CARBOXYFLUORESCEIN DIACETATE SUCCINIMIDYL ESTER; FLUOROCHROME;

ADOPTIVE TRANSFER; CELL ACTIVATION; CELL ASSAY; CELL FUNCTION; CELL ISOLATION; CELL LABELING; CELL MATURATION; CELL SUBPOPULATION; CELLULAR DISTRIBUTION; CYTOLOGY; CYTOTOXICITY; FLUORESCENCE ACTIVATED CELL SORTING; FLUORESCENCE RESONANCE ENERGY TRANSFER; FUNCTIONAL ASSESSMENT; HUMAN; IMMUNITY; IMMUNOLOGICAL TECHNIQUE; IN VITRO STUDY; IN VIVO STUDY; NATURAL KILLER CELL; NONHUMAN; PURIFICATION; REVIEW; T LYMPHOCYTE;

EID: 20544459766     PISSN: 09527915     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.coi.2005.05.012     Document Type: Review

References (63)

1. M.J. Smyth, and D.I. Godfrey NKT cells and tumour immunity-a double-edged sword Nat Immunol 1 2000 459 460
2. D.I. Godfrey, and M. Kronenberg Going both ways: immune regulation via CD1d-dependent NKT cells J Clin Invest 114 2004 1379 1388
3. H.J. van der Vliet, J.W. Molling, B.M. von Blomberg, N. Nishi, W. Kolgen, A.J. van den Eertwegh, H.M. Pinedo, G. Giaccone, and R.J. Scheper The immunoregulatory role of CD1d-restricted natural killer T cells in disease Clin Immunol 112 2004 8 23
4. K.J. Hammond, and D.I. Godfrey NKT cells: potential targets for autoimmune disease therapy? Tissue Antigens 59 2002 353 363
5. M.J. Smyth, N.Y. Crowe, Y. Hayakawa, K. Takeda, H. Yagita, and D.I. Godfrey NKT cells - conductors of tumour immunity? Curr Opin Immunol 14 2002 165 171
6. J. Swann, N.Y. Crowe, Y. Hayakawa, D.I. Godfrey, and M.J. Smyth Regulation of antitumour immunity by CD1d-restricted NKT cells Immunol Cell Biol 82 2004 323 331
7. L. Van Kaer alpha-Galactosylceramide therapy for autoimmune diseases: prospects and obstacles Nat Rev Immunol 5 2005 31 42
8. K.J.L. Hammond, L.D. Poulton, L.J. Palmisano, P.A. Silveira, D.I. Godfrey, and A.G. Baxter alpha/beta-T cell receptor (TCR)+CD4-CD8- (NKT) thymocytes prevent insulin-dependent diabetes mellitus in nonobese diabetic (NOD)/Lt mice by the influence of interleukin (IL)-4 and/or IL-10 J Exp Med 187 1998 1047 1056
9. N.Y. Crowe, M.J. Smyth, and D.I. Godfrey A critical role for natural killer T cells in immunosurveillance of methylcholanthrene-induced sarcomas J Exp Med 196 2002 119 127
10. S. Sharif, G.A. Arreaza, P. Zucker, Q.S. Mi, J. Sondhi, O.V. Naidenko, M. Kronenberg, Y. Koezuka, T.L. Delovitch, and J.M. Gombert Activation of natural killer T cells by alpha-galactosylceramide treatment prevents the onset and recurrence of autoimmune Type 1 diabetes Nat Med 7 2001 1057 1062
11. S. Hong, M.T. Wilson, I. Serizawa, L. Wu, N. Singh, O.V. Naidenko, T. Miura, T. Haba, D.C. Scherer, and J. Wei The natural killer T-cell ligand alpha-galactosylceramide prevents autoimmune diabetes in non-obese diabetic mice Nat Med 7 2001 1052 1056
12. D.I. Godfrey, H.R. MacDonald, M. Kronenberg, M.J. Smyth, and L. Van Kaer NKT cells: what's in a name? Nat Rev Immunol 4 2004 231 237 This review examines the history of NKT cells including how these cells have been defined in mice and humans.
13. K. Benlagha, A. Weiss, A. Beavis, L. Teyton, and A. Bendelac In vivo identification of glycolipid antigen-specific T cells using fluorescent CD1d tetramers J Exp Med 191 2000 1895 1903
14. J.L. Matsuda, O.V. Naidenko, L. Gapin, T. Nakayama, M. Taniguchi, C.R. Wang, Y. Koezuka, and M. Kronenberg Tracking the response of natural killer T cells to a glycolipid antigen using CD1d tetramers J Exp Med 192 2000 741 754
15. J. Schumann, R.B. Voyle, B.Y. Wei, and H.R. MacDonald Cutting Edge: Influence of the TCR Vbeta Domain on the Avidity of CD1d:alpha- Galactosylceramide Binding by Invariant Valpha14 NKT Cells J Immunol 170 2003 5815 5819
16. P. Dellabona, G. Casorati, B. Friedli, L. Angman, F. Sallusto, A. Tunnacliffe, E. Roosneek, and A. Lanzavecchia In vivo persistence of expanded clones specific for bacterial antigens within the human T cell receptor alpha/beta CD4-8- subset J Exp Med 177 1993 1763 1771
17. S.M. Tahir, O. Cheng, A. Shaulov, Y. Koezuka, G.J. Bubley, S.B. Wilson, S.P. Balk, and M.A. Exley Loss of IFN-gamma production by invariant NK T cells in advanced cancer J Immunol 167 2001 4046 4050
18. P. Gadue, and P.L. Stein NK T cell precursors exhibit differential cytokine regulation and require Itk for efficient maturation J Immunol 169 2002 2397 2406
19. M. Stenstrom, M. Skold, A. Ericsson, L. Beaudoin, S. Sidobre, M. Kronenberg, A. Lehuen, and S. Cardell Surface receptors identify mouse NK1.1+ T cell subsets distinguished by function and T cell receptor type Eur J Immunol 34 2004 56 65
20. K. Benlagha, T. Kyin, A. Beavis, L. Teyton, and A. Bendelac A thymic precursor to the NK T cell lineage Science 296 2002 553 555
21. P.T. Lee, A. Putnam, K. Benlagha, L. Teyton, P.A. Gottlieb, and A. Bendelac Testing the NKT cell hypothesis of human IDDM pathogenesis J Clin Invest 110 2002 793 800
22. D.G. Pellicci, K.J. Hammond, A.P. Uldrich, A.G. Baxter, M.J. Smyth, and D.I. Godfrey A natural killer T (NKT) cell developmental pathway involving a thymus-dependent NK1.1(-)CD4(+) CD1d-dependent precursor stage J Exp Med 195 2002 835 844
23. D.V. Baev, X.H. Peng, L. Song, J.R. Barnhart, G.M. Crooks, K.I. Weinberg, and L.S. Metelitsa Distinct homeostatic requirements of CD4+ and CD4- subsets of V{alpha}24-invariant natural killer T cells in humans Blood 104 2004 4150 4156
24. P. Batard, J. Szollosi, I. Luescher, J.C. Cerottini, R. MacDonald, and P. Romero Use of phycoerythrin and allophycocyanin for fluorescence resonance energy transfer analyzed by flow cytometry: advantages and limitations Cytometry 48 2002 97 105
25. A.K. Stanic, R. Shashidharamurthy, J.S. Bezbradica, N. Matsuki, Y. Yoshimura, S. Miyake, E.Y. Choi, T.D. Schell, L. Van Kaer, and S.S. Tevethia Another view of T cell antigen recognition: cooperative engagement of glycolipid antigens by Va14Ja18 natural T(iNKT) cell receptor J Immunol 171 2003 4539 4551
26. K.J. Hammond, D.G. Pellicci, L.D. Poulton, O.V. Naidenko, A.A. Scalzo, A.G. Baxter, and D.I. Godfrey CD1d-restricted NKT cells: an interstrain comparison J Immunol 167 2001 1164 1173
27. T. Kenna, L. Golden-Mason, S.A. Porcelli, Y. Koezuka, J.E. Hegarty, C. O'Farrelly, D.G. Doherty, and L.G. Mason NKT cells from normal and tumour-bearing human livers are phenotypically and functionally distinct from murine NKT cells J Immunol 171 2003 1775 1779
28. L.S. Metelitsa, H.W. Wu, H. Wang, Y. Yang, Z. Warsi, S. Asgharzadeh, S. Groshen, S.B. Wilson, and R.C. Seeger Natural killer T cells infiltrate neuroblastomas expressing the chemokine CCL2 J Exp Med 199 2004 1213 1221
29. D.M. Andrews, H.E. Farrell, E.H. Densley, A.A. Scalzo, G.R. Shellam, and M.A. Degli-Esposti NK1.1+ cells and murine cytomegalovirus infection: what happens in situ? J Immunol 166 2001 1796 1802
30. F. Geissmann, T.O. Cameron, S. Sidobre, N. Manlongat, M. Kronenberg, M.J. Briskin, M.L. Dustin, and D.R. Littman Intravascular immune surveillance by CXCR6+ NKT cells patrolling liver sinusoids PLoS Biol 3 2005 e113 (DOI: 10.1371/journal.pbio.0030113) This paper describes an experimental system that has enabled the first direct study of NKT cell trafficking behaviour in a live mouse.
31. L. Gapin, J.L. Matsuda, C.D. Surh, and M. Kronenberg NKT cells derive from double-positive thymocytes that are positively selected by CD1d Nat Immunol 2 2001 971 978
32. M. Margalit, Y. Ilan, M. Ohana, R. Safadi, R. Alper, Y. Sherman, V. Doviner, E. Rabbani, D. Engelhardt, and A. Nagler Adoptive transfer of small numbers of DX5+ cells alleviates graft-versus-host disease in a murine model of semiallogeneic bone marrow transplantation: a potential role for NKT lymphocytes Bone Marrow Transplant 35 2005 191 197
33. J.E. Gumperz, S. Miyake, T. Yamamura, and M.B. Brenner Functionally distinct subsets of CD1d-restricted natural killer T cells revealed by CD1d tetramer staining J Exp Med 195 2002 625 636
34. R.A. Campos, M. Szczepanik, A. Itakura, M. Akahira-Azuma, S. Sidobre, M. Kronenberg, and P.W. Askenase Cutaneous immunization rapidly activates liver invariant Valpha14 NKT cells stimulating B-1 B cells to initiate T cell recruitment for elicitation of contact sensitivity J Exp Med 198 2003 1785 1796
35. P.T. Lee, K. Benlagha, L. Teyton, and A. Bendelac Distinct functional lineages of human V(alpha)24 natural killer T cells J Exp Med 195 2002 637 641
36. A. Hameg, C. Gouarin, J.M. Gombert, S.M. Hong, L. Van Kaer, J.F. Bach, and A. Herbelin IL-7 up-regulates IL-4 production by splenic NK1.1(+) and NK1.1(-) MHC class I-like/CD1-dependent CD4(+) T cells J Immunol 162 1999 7067 7074
37. Y. Hayakawa, S.P. Berzins, N.Y. Crowe, D.I. Godfrey, and M.J. Smyth Antigen-induced tolerance by intrathymic modulation of self-recognizing inhibitory receptors Nat Immunol 5 2004 590 596
38. K.J. Hammond, S.B. Pelikan, N.Y. Crowe, E. Randle-Barrett, T. Nakayama, M. Taniguchi, M.J. Smyth, I.R. van Driel, R. Scollay, and A.G. Baxter NKT cells are phenotypically and functionally diverse Eur J Immunol 29 1999 3768 3781
39. M. Kronenberg Toward an understanding of NKT cell biology: Progress and Paradoxes Annu Rev Immunol 23 2005 877 900
40. Y. Yang, A. Ueno, M. Bao, Z. Wang, J.S. Im, S. Porcelli, and J.W. Yoon Control of NKT cell differentiation by tissue-specific microenvironments J Immunol 171 2003 5913 5920
41. M.A. Exley, and M.J. Koziel To be or not to be NKT: natural killer T cells in the liver Hepatology 40 2004 1033 1040
42. S.P. Berzins, K. Kyparissoudis, D.G. Pellicci, K.J. Hammond, S. Sidobre, A. Baxter, M.J. Smyth, M. Kronenberg, and D.I. Godfrey Systemic NKT cell deficiency in NOD mice is not detected in peripheral blood: implications for human studies Immunol Cell Biol 82 2004 247 252
43. •].
44. • ] provide up to date and detailed information on how best to culture human NKT cells and generate NKT cell lines.
45. S. Fujii, K. Shimizu, R.M. Steinman, and M.V. Dhodapkar Detection and activation of human Valpha24+ natural killer T cells using alpha-galactosyl ceramide-pulsed dendritic cells J Immunol Methods 272 2003 147 159
46. C. Carnaud, D. Lee, O. Donnars, S.H. Park, A. Beavis, Y. Koezuka, and A. Bendelac Cutting edge: Cross-talk between cells of the innate immune system: NKT cells rapidly activate NK cells J Immunol 163 1999 4647 4650
47. G. Eberl, P. Brawand, and H.R. MacDonald Selective bystander proliferation of memory CD4(+) and CD8(+) T cells upon NK T or T cell activation J Immunol 165 2000 4305 4311
48. D. Zhou, J. Mattner, C. Cantu Iii, N. Schrantz, N. Yin, Y. Gao, Y. Sagiv, K. Hudspeth, Y. Wu, and T. Yamashita Lysosomal glycosphingolipid recognition by NKT cells Science 306 2004 1786 1789 This study uses a broad range of techniques to identify a naturally occurring mammalian ligand capable of activating, and possibly selecting for, NKT cells.
49. J.L. Matsuda, L. Gapin, J.L. Baron, S. Sidobre, D.B. Stetson, M. Mohrs, R.M. Locksley, and M. Kronenberg Mouse V alpha 14i natural killer T cells are resistant to cytokine polarization in vivo Proc Natl Acad Sci USA 100 2003 8395 8400
50. T. Chun, M.J. Page, L. Gapin, J.L. Matsuda, H. Xu, H. Nguyen, H.S. Kang, A.K. Stanic, S. Joyce, and W.A. Koltun CD1d-expressing dendritic cells but not thymic epithelial cells can mediate negative selection of NKT cells J Exp Med 197 2003 907 918
51. J.K. Sandberg, C.A. Stoddart, F. Brilot, K.A. Jordan, and D.F. Nixon Development of innate CD4+ alpha-chain variable gene segment 24 (Valpha24) natural killer T cells in the early human fetal thymus is regulated by IL-7 Proc Natl Acad Sci USA 101 2004 7058 7063
52. M.J. Smyth, N.Y. Crowe, D.G. Pellicci, K. Kyparissoudis, J.M. Kelly, K. Takeda, H. Yagita, and D.I. Godfrey Sequential production of interferon-gamma by NK1.1(+) T cells and natural killer cells is essential for the antimetastatic effect of alpha-galactosylceramide Blood 99 2002 1259 1266
53. R. Nakagawa, I. Nagafune, Y. Tazunoki, H. Ehara, H. Tomura, R. Iijima, K. Motoki, M. Kamishohara, and S. Seki Mechanisms of the antimetastatic effect in the liver and of the hepatocyte injury induced by alpha-galactosylceramide in mice J Immunol 166 2001 6578 6584
54. O. Akbari, P. Stock, E. Meyer, M. Kronenberg, S. Sidobre, T. Nakayama, M. Taniguchi, M.J. Grusby, R.H. DeKruyff, and D.T. Umetsu Essential role of NKT cells producing IL-4 and IL-13 in the development of allergen-induced airway hyperreactivity Nat Med 9 2003 582 588
55. J.L. Matsuda, L. Gapin, S. Sidobre, W.C. Kieper, J.Y.T. Tan, R. Ceredig, C.D. Surh, and M. Kronenberg Homeostasis of V(alpha)14i NKT cells Nat Immunol 3 2002 966 974
56. N.Y. Crowe, A.P. Uldrich, K. Kyparissoudis, K.J. Hammond, Y. Hayakawa, S. Sidobre, R. Keating, M. Kronenberg, M.J. Smyth, and D.I. Godfrey Glycolipid antigen drives rapid expansion and sustained cytokine production by NK T cells J Immunol 171 2003 4020 4027
57. M.T. Wilson, C. Johansson, D. Olivares-Villagomez, A.K. Singh, A.K. Stanic, C.R. Wang, S. Joyce, M.J. Wick, and L. Van Kaer The response of natural killer T cells to glycolipid antigens is characterized by surface receptor down-modulation and expansion Proc Natl Acad Sci USA 100 2003 10913 10918
58. M. Nieda, M. Okai, A. Tazbirkova, H. Lin, A. Yamaura, K. Ide, R. Abraham, T. Juji, D.J. Macfarlane, and A.J. Nicol Therapeutic activation of Valpha24+Vbeta11+ NKT cells in human subjects results in highly coordinated secondary activation of acquired and innate immunity Blood 103 2004 383 389
59. K. Miyamoto, S. Miyake, and T. Yamamura A synthetic glycolipid prevents autoimmune encephalomyelitis by inducing T(H)2 bias of natural killer T cells Nature 413 2001 531 534
60. J. Schmieg, G. Yang, R.W. Franck, and M. Tsuji Superior protection against malaria and melanoma metastases by a C-glycoside analogue of the natural killer T cell ligand alpha-Galactosylceramide J Exp Med 198 2003 1631 1641
61. Y. Ueno, S. Tanaka, M. Sumii, S. Miyake, S. Tazuma, M. Taniguchi, T. Yamamura, and K. Chayama Single dose of OCH improves mucosal T helper type 1/T helper type 2 cytokine balance and prevents experimental colitis in the presence of valpha14 natural killer T cells in mice Inflamm Bowel Dis 11 2005 35 41
62. V.V. Parekh, A.K. Singh, M.T. Wilson, D. Olivares-Villagomez, J.S. Bezbradica, H. Inazawa, H. Ehara, T. Sakai, I. Serizawa, and L. Wu Quantitative and qualitative differences in the in vivo response of NKT cells to distinct alpha- and beta-anomeric glycolipids J Immunol 173 2004 3693 3706
63. S.P. Berzins, A.D. Cochrane, D.G. Pellicci, M.J. Smyth, and D.I. Godfrey Limited correlation between human thymus and blood NKT cell content revealed by an ontogeny study of paired tissue samples Eur J Immunol 35 2005 1399 1407